Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and PEG-Interferon alfa-2a in Skin SCC
NCT00423397Phase 2Unknown
- Sponsor
- University of California, San Diego
- Start
- Sep 2006
- Primary completion
- Jan 2008
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a in squamous cell carcinoma of the skin (SCC), sponsored by University of California, San Diego. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
squamous cell carcinoma of the skin (SCC)
Beyond the preview
Go deeper on NCT00423397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423397.